Home

Monday 30 April 2018

Cosmetic Preservative Market Is Estimate To Reach $458.8 Million By 2024: Grand View Research, Inc.

The global COSMETIC PRESERVATIVE MARKET is expected to reach USD 458.8 million by 2024, according to a new report by Grand View Research, Inc. The increasing demand for natural preservatives such as thyme, clove, cinnamon and tea tree coupled with growing awareness for personal hygiene are some of the major factors that augment the growth of the Cosmetic Preservative Market. 

        
The multiplying demand for sunscreens, lotions, and anti-ageing creams in Asia Pacific is also anticipated to positively impact the demand growth over the forecast period. Growing demand for herbal & natural ingredients in cosmetics is expected to drive the demand for organic preservatives. 
Browse Research Report on Cosmetic Preservative Market:

Further key findings from the report suggest:

  • The phenol derivatives emerged as the leading product segment and accounted for 35.7% of total revenue in 2015.Growing demand for phenoxyethanol used in creams and lotions is spur market growth over the forecast period. The segment is also expected to witness the highest growth of 6.4% from 2016 to 2024.
  • Skin & sun care emerged as the leading application segment and accounted for 39.2% of global revenue in 2015. Growing awareness regarding the harmful effects of ultra-violet rays on the skin is expected to spur the Cosmetic Preservative Market growth.
  • Cosmetic preservatives demand in toiletries is also expected to witness significant growth over the forecast period. Rising standard of living particularly in Asia Pacific has prompted the demand for toiletries in the recent past which is expected to propel the demand for cosmetic preservatives in this segment.
  • Asia Pacific emerged as the leading regional market and accounted for 35.0% of global revenue in 2015. Asia Pacific is expected to witness the highest growth on account of the growing production and demand of cosmetic products.
  • New product formulations and demand for herbal & organic ingredients in cosmetics is expected to drive the regional market over the forecast period. Rising economic standards and growing awareness about personal grooming and hygiene are also anticipated to boost the cosmetics market growth which will, in turn, have a positive impact on the global Cosmetic Preservative Market.
  • Some leading companies operating in the global cosmetic preservatives market include Lonza Group, The Dow Chemical Company, Ashland Inc., Symrise AG, BASF SE, Clariant AG, Akema Fine Chemicals, Brenntag AG, and Chemipol.
View more reports of this category by Grand View Research at
Grand View Research has segmented the cosmetic preservatives market on the basis of product, application, and region:
Global Cosmetic Preservatives Product Outlook (Revenue, USD Million, 2014 - 2024)
  • Paraben esters
  • Formaldehyde donors
  • Phenol derivatives
  • Alcohols
  • Quaternary compounds
  • Organic acids
  • Others
Global Cosmetic Preservatives Application Outlook (Revenue, USD Million, 2014 - 2024)
  • Skin & sun care
  • Hair care
  • Toiletries
  • Fragrances & perfumes
  • Makeup & color
  • Others
View press release of this research report by Grand View Research:

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Hormone Replacement Therapy Market Is Forecast To Reach $28.4 Billion By 2022: Grand View Research, Inc.

Global HORMONE REPLACEMENT THERAPY MARKET is expected to reach USD 28.4 billion by 2022, according to a new report by Grand View Research, Inc. Increasing geriatric and neonatal population base, growing cases of hormonal imbalances, and large presence of unmet healthcare needs in emerging economies are some vital impact rendering drivers. 
Estrogen replacement therapy dominated the market in 2015. Moreover, the rising number of women reaching the menopausal age is expected to drive the demand for these treatments over the forecast period.
   
Furthermore, rise in premature births that lead to genital disorders and slower rate of growth in these neonates are anticipated to fuel the demand for growth hormone therapy. According to statistics provided by the CDC, over 15 million babies were born preterm in 2014 annually. This number is anticipated to rise over the next seven years and become a leading cause for disabilities, illnesses, arrested development, and mortality. 
Browse Research Report on Hormone Replacement Therapy Market:

Further key findings from the study suggest:

  • Estrogen therapy is expected to dominate the product segment and hold over 50.0% of the market share by 2022. This growth can be attributed to the increasing focus of healthcare bodies such as the Women’s Health Initiative, The North America Menopause Society, and The British Menopause Society, on providing safe replacement therapy.
  • The parenteral route of administration is commonly used for delivery of drugs such as Nutropin, Signifor, Genotropin, and Tev-Tropin. Other routes such as pen-based delivery systems and implants are gaining popularity owing to higher patient comfort and ease-of-use. Furthermore, technological advancements in the field providing higher bioavailability of drug and needle-free administration are predicted to positively impact growth.
  • Menopause and their vasomotor symptoms are expected to be the most prevalent disease over the forecast period owing to increasing number of women approaching the menopausal age. The segment is predicted to hold about 40.0% of the market share by 2022.
  • North America, particularly the U.S. dominated the market and held about 35.0% of the total revenue in 2015. Existence of well-regulated healthcare system and presence of a large pool of target population are a few factors that promote growth. Countries such as South Africa, China, India, and Brazil are anticipated to witness lucrative growth over the forecast period, with China predicted to have the fastest growth of over 10.0%.
  • Some key companies catering to hormone replacement therapies include Pfizer, Inc., Merck Serono, Novo Nordisk, Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and Genentech. Introduction of new formulations and development of innovative drug delivery systems are expected to be a few initiatives taken by these players over the forecast period. 
View more reports of this category by Grand View Research at
Grand View Research has segmented the hormone replacement therapy market on the basis of product, route of administration, disease type, and region 
Hormone Replacement Therapy Market Product Outlook (Revenue, USD Million, 2012 - 2022)
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Other
Hormone Replacement Therapy Market Route Of Administration Outlook (Revenue, USD Million, 2012 - 2022)
  • Oral
  • Parenteral
  • Transdermal
  • Other
Hormone Replacement Therapy Market Type Of Disease Outlook (Revenue, USD Million, 2012 - 2022)
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Other

View press release of this research report by Grand View Research:

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com
Subscribe to: Posts (Atom)